期刊文献+

PET/CT在眼部肿瘤诊断中的应用 被引量:7

Application of positron emission tomography/computed tomography in the diagnosis of ocular tumors
下载PDF
导出
摘要 正电子发射断层与计算机断层成像(PET/CT)是将PET与CT 2种图像加以融合,PET提供病灶的代谢信息,CT显示病灶的解剖特征.利用PET/CT进行一次扫描可获得全身断层图像,可以高度敏感地反映体内生理及生化过程并对其精确定位.自1998年PET/CT机用于医疗体系以来,作为临床上重要的影像学诊断工具,近年来已被逐渐应用于检测眼部肿瘤,如脉络膜黑色素瘤、脉络膜转移癌、视网膜母细胞瘤、眼部淋巴瘤、泪腺腺样囊性癌等.就PET/CT的原理、标准摄取值(SUV)在临床中的应用价值以及PET/CT在眼部的临床应用进展进行综述. Positron emission tomography and computed tomography (PET/CT) fusion combines the advantages of both imaging modalities (quantification of metabolic activity and anatomic localization of tumor).With once scan,whole-body imagings can obtain with highly sensitivity to reflect the physiological and biochemical processes of the body and accurate position about the lesions.As an important clinical imaging diagnostic tool,since the first combined PET/CT scanner introduced to the medical community in 1998,it's has been gradually applied in the detection of ophthalmic tumors in recent years,such as choroidal melanoma,choroidal metastatic carcinoma,retinoblastoma,ocular lymphoma,adenoid cystic carcinoma of lacrimal gland etc.In this paper,the principle of PET/CT,the clinical application value of standardized uptake value (SUV) and the clinical application of PET/CT in ocular tumors were summarized.
作者 张蕾 宋国祥
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2015年第4期380-384,共5页 Chinese Journal Of Experimental Ophthalmology
关键词 正电子发射断层与计算机断层成像 18氟-氟代脱氧葡萄糖 标准摄取值 眼部肿瘤 Positron emission tomography and computed tomography Fluorine-18-labeled fluorodeoxyglucose Standardized uptake value Ocular tumor
  • 相关文献

参考文献43

  • 1Bomanji JB, Costa DC, Eu PJ. Clinical role of positron emission tomography in oncology [ J ]. Lancet Oucol, 2001,2 ( 3 ) : 157-164.
  • 2Finger PT, Chin K, Iacob CE. lS-Fluorine-lahelled 2-deoxy-2-fluoro-D- glucose positron emission tomography/computed tomography standardized uptake values:a non-invasive biomarker for the risk of metastasis from choroidal melanoma [ J ]. BJO, 2006,90 ( 10 ) : 12263 - 12266.
  • 3Bunyaviroch T, Coleman RE. PET evaluation of lung cancer[ J]. Nucl Med, 2006,47 ( 3 ) : 451-469.
  • 4Blodgett T, Meltzer CC, Townsend DW. PET/CT : form and function [ J ]. Radidogy,2007,242 ( 2 ) : 360-355.
  • 5Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of ^18F-FDG PET in oncology[J]. J Nucl Med,2008,49 (3) : 480-505.
  • 6李明耀,朱小东,徐国增,曲颂,苏芳.^(18)F-FDG PET/CT显像SUV值与头颈部鳞癌预后关系的Meta分析[J].中国癌症防治杂志,2010,2(4):290-295. 被引量:3
  • 7Griffeth LK. Use of PET/CT scanning in cancer patients : technical and practical considerations[ J]. BUMC Proc ,2005,18 (4) : 321-330.
  • 8Burrell SC, van den Abbeele AD. 2-deoxy-2-[ F-18 ] fluoro-D-glucose- positron emission tomography of the head and neck : an atlas of normal uptake and variants[ J]. Mol Imaging Biol,2005,7 (3) :244-256.
  • 9Zincirkeser S, Sahin E, Halac M, et al. Standardized uptake values of normal organs on 18F-fluorodeoxyglucose positron emission tomography and computed tomography imaging[ J ]. J Int Med Res, 2007,35 ( 2 ) : 231-236.
  • 10Uematsu H, Sadato N, Yonekura Y, et al. Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG[ J]. J Nucl Med, 1998,39 ( 12 ) : 2121-2127.

二级参考文献30

  • 1孟雪,刘希军,于金明,付政,杨国仁,韩安勤,孙新东,孔莉,郑劲松.^(18)F-FDG PET/CT显像SUV与鼻咽癌预后的关系[J].中华核医学杂志,2007,27(3):183-183. 被引量:3
  • 2Liao CT,Chang JT,Wang HM,et al.Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes[J].Int J Radiat Oncol Biol Phys,2009,73(3):764-771.
  • 3SuzukiK,NishiokaT,HommaA,et al.Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer:does the standardized uptade value predict treatment outcome[J].Jpn J Radiol,2009,27(6):237-242.
  • 4Hofele C,Freier K,Thiele OC,et al.High2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with rehuced overall survival in patients with oral squamous cell carcinoma[J].Oral Oncol,2009,45(11):963-967.
  • 5Stokkel MP,Ten-Broek FW,van-Rijk PP.The role of FDG PET in the clinical management of head and neck cancer[J].Oral Oncol,1998,34:466-471.
  • 6Scott AM.Current status of positrom emission tomography in oncology[J].Intern Med J,2001,31:27-36.
  • 7Minn H,Clavo AC,Grenman R,et al.In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamouscell carcinoma of the head and neck[J].J Nucl Med,1995,36:252-258.
  • 8Haberkorn U,Strauss LG,Reisser C,et al.Glucose uptake,perfusion,and cell proliferation in head and neck tumors:relation of positron emission tomography to flow cytometry[J].J Nucl Med,1991,32:1548-1555.
  • 9Minn H,Lapela M,Klemi PJ,et al.Prediction of survival with fluorine-18-fluoro-deox-yglucose and PET in head and neck cancer[J].J Nucl Med,1997,38:1907-1911.
  • 10Steels E,Paesmans M,Berghmans T,et al.Role of p53 as a prognostic factor for survival in lung cancer:a systematic review of the literature with a meta-analysis[J].Eur Respir J,2001,18:705-719.

共引文献2

同被引文献79

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部